Skip to main content

Table 4 The development of individual MS components after 5 years

From: Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study

 

Abdominal obesity

Hyperglycemia

Hypertension

Low HDL-C

High TG

Whole cohort

317/2350

(13.5%)

578/2350 (24.6%)

489/2350 (20.8%)

228/2350

(9.7%)

673/2350

(28.6%)

Subjects without any MS components at baseline

77/1171

(6.6%)

175/1171

(14.9%)

125/1171

(10.7%)

77/1171

(6.6%)

155/1171

(13.2%)

  1. MS, metabolic syndrome; HDL-C, high density lipoprotein cholesterol; TG, triglyceride
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840